Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmaniadonovani

Abstract

The FML antigen of Leishmania donovani in combination with saponin, aluminum hydroxide (Al(OH) 3) and Freund's incomplete adjuvant (FIA) was used in vaccines tested in an outbred murine model of visceral leishmaniasis, either through intraperitoneal or subcutaneous routes. The humoral response was significantly higher in the groups treated with FML+saponin or FML+Al(OH) 3 than in controls, both before and after the infection. Animals immunized by the i.p. route developed higher antibody titres. A significant and specific reduction of parasitic load in relation to saline (85%, p<0.01) and saponin ( p<0.025) controls, was seen in animals treated with FML+saponin by the i.p. Coincidentally with this reduction, an increase in antibodies of the IgG2a subtype was detected only in animals treated with FML+saponin i.p. A reduction of 88% in parasitic load was achieved by the combination of FML+Al(OH) 3 (s.c.), but the Al(OH) 3 treatment itself accounted for 68% of this protection. In our conditions, vaccination with FML+saponin i.p. was superior to other treatments and had no toxic effect due to saponin.